The report covers:
“Liquid embolization is commonly used, mainly the iodinated oil. We also use PV particles, which is polyethylene, blank microsphere and drug carrying microspheres. Many companies are producing drug carrying microsphere now, some are multi-drug carrying and some are single drug carrying. Drug carrying microsphere is the best embolization type now, it’s like continuous infusion chemotherapy, where the drug is continuously reaching the tumor.”
– Interventional Radiologist, Tumor Embolization China
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as recent NMPA approval of Sirtex Medical’s SIR-Sphere Y-90 resin microsphere for treatment of patients with colorectal cancer liver metastasis; China Grand Pharmaceutical’s acquisition of rights from Shenming Medical Technology Company of an innovative thermosensitive embolic agent for the treatment of liver cancer are covered in the report.
What’s in it for you?